Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

PDF] Chronic Rhinosinusitis with Nasal Polyps.

Biomedicines, Free Full-Text

Mepolizumab Induced Loss of Smell Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps From the SYNAPSE Study

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Mepolizumab may reduce size of nasal polyps, need for surgery in chronic rhinosinusitis

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study - Aikaterini Detoraki, Eugenio Tremante, Maria D'Amato, Cecilia Calabrese, Claudia

Study Designs NUCALA (mepolizumab) for HCPs

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study